2015 Andesu Annual Report: Net profit of RMB 2.00 billion, methionine increased revenue from functional products by 28%

Andisu's 2015 operating income was RMB15.17 billion, net profit was RMB2.00 billion, and net profit attributable to shareholders of listed companies was RMB1.53 billionRevenue from functional products was RMB10.31 billion, up 28% YoY, and operating costs were RMB4.98 billion, down 4% YoYThe main revenue of functional products is mainly driven by methionine, due to higher prices, supply is less than demand, Andesu homeward to promote methionine sales, so that functional product revenue increased by 28%B9Y
On July 27, 2015, blue star new material (later changed to Andy Su) acquired 85% common equity shares of AndesU Nutrition Group Co., Ltd., and transferred all rights and obligations related to the assets to China Blue Star (Group) Co., LtdBased on this, Blue Star New material will no longer consolidate assets as of July 27, 2015On December 19, "Blue Star Chemical New Materials Co., Ltd." changed its name to "Blue Star Andesu Co., Ltd."B9Y
Andesu is a global industry leader focused on the development, production and sale of animal nutrition additives, with over 75 years of production and research and development experience, including methionine, vitamins, enzymes and other animal nutrition additivesWith its extensive product portfolio, well-established sales platform and strong technical support team, Andesu offers innovative animal nutrition additive solutions to more than 2,500 customers in more than 140 countries worldwideB9Y
The main drivers of this year's performance growth are: 1, Andesu products are mainly in the animal feed nutrition additivemarket market sales, the market is mainly driven by global meat consumptionIn this market, the company mainly serves the poultry feed market, especially the methionine marketThe market size continues to grow each year due to increased consumption of poultry meat and continued industrialization of the poultry industry;2 Exchange rate impact: Andesu sales cover many countries and regions, mostly denominated in US dollars and partly in euros or rmb In terms of costs, Andesu's main plants are located in Europe and China, while most of the raw materials are purchased in euros and dollars; B9Y
　　Outlook 2016: 1, safety is the first priority In 2016, the company aims to achieve zero accident targets and further improve safety performance; As the new capacity announced in recent years has finally been released to the market after a series of delays, the market supply and demand supply and demand tend to balance, methionine prices will fall as expected As a result, proactive price management of functional products has been key to achieving business objectives; in the past few years, Andesu has developed new products, such as the release of The Selisseo ® in 2014 (a specialty product containing selenium) and the release of Advance ® (a new enzyme product) in 2015 Andesu will continue to invest in the plant to expand capacity, and will continue to invest in research and development innovation, with the aim of being able to bring a new product to the market each year B9Y Andisu's 2015 operating income was RMB15.17 billion, net profit was RMB2.00 billion, and net profit attributable to shareholders of listed companies was RMB1.53 billion Revenue from functional products was RMB10.31 billion, up 28% YoY, and operating costs were RMB4.98 billion, down 4% YoY The main revenue of functional products is mainly driven by methionine, due to higher prices, supply is less than demand, Andesu homeward to promote methionine sales, so that functional product revenue increased by 28% B9Y
　　On July 27, 2015, blue star new material (later changed to Andy Su) acquired 85% common equity shares of AndesU Nutrition Group Co., Ltd., and transferred all rights and obligations related to the assets to China Blue Star (Group) Co., Ltd Based on this, Blue Star New material will no longer consolidate assets as of July 27, 2015 On December 19, "Blue Star Chemical New Materials Co., Ltd." changed its name to "Blue Star Andesu Co., Ltd." B9Y
　　Andesu is a global industry leader focused on the development, production and sale of animal nutrition additives, with over 75 years of production and research and development experience, including methionine, vitamins, enzymes and other animal nutrition additives With its extensive product portfolio, well-established sales platform and strong technical support team, Andesu offers innovative animal nutrition additive solutions to more than 2,500 customers in more than 140 countries worldwide B9Y
　　The main drivers of this year's performance growth are: 1, Andesu products are mainly in the animal feed nutrition additivemarket market sales, the market is mainly driven by global meat consumption In this market, the company mainly serves the poultry feed market, especially the methionine market The market size continues to grow each year due to increased consumption of poultry meat and continued industrialization of the poultry industry;2 Exchange rate impact: Andesu sales cover many countries and regions, mostly denominated in US dollars and partly in euros or rmb In terms of costs, Andesu's main plants are located in Europe and China, while most of the raw materials are purchased in euros and dollars; B9Y
　　Outlook 2016: 1, safety is the first priority In 2016, the company aims to achieve zero accident targets and further improve safety performance; As the new capacity announced in recent years has finally been released to the market after a series of delays, the market supply and demand supply and demand tend to balance, methionine prices will fall as expected As a result, proactive price management of functional products has been key to achieving business objectives; in the past few years, Andesu has developed new products, such as the release of The Selisseo ® in 2014 (a specialty product containing selenium) and the release of Advance ® (a new enzyme product) in 2015 Andesu will continue to invest in the plant to expand capacity, and will continue to invest in research and development innovation, with the aim of being able to bring a new product to the market each year B9Y
Share it on feed